For research use only
| Cat No. | ABC-TC3185 |
| Product Type | Mouse Primary Cells |
| Cell Type | Fibroblast |
| Species | C57BL/6 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Dermal |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Mouse dermal fibroblasts are isolated from tissue of 1-day-old neonatal mice.
C57BL/6 Mouse Dermal Fibroblasts are primary cells isolated from the skin of mice. These cells reside exclusively within the dermis layer of the skin. Following primary culture, these cells are cryopreserved. These mouse fibroblasts play crucial roles in extracellular matrix synthesis, wound contraction, and immune modulation through cytokine signaling. Studies have demonstrated their implication in pathological fibrosis, scleroderma-like connective tissue disorders, and diabetic chronic wound healing impairment due to hypercontractility and ECM dysregulation, driving therapeutic development. The cells exhibit a characteristic spindle-shaped morphology and are validated by fibroblast-specific protein 1 (FSP1/S100A4). For optimal performance, repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | C57BL/6 Mouse Dermal Fibroblasts, Mouse Dermal Fibroblasts, Dermal Fibroblasts, Fibroblasts, FibCs, C57BL/6 Dermal Fibroblasts |
| Species | C57BL/6 Mouse |
| Cat.No | ABC-TC3185 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Dermal |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
C57BL/6 Mouse Dermal Fibroblasts can be used as an in vitro model to study the pathogenesis of fibrotic skin disorders in disease conditions such as scleroderma and diabetic chronic wounds. For example, by investigating molecular pathways like TGF-β/Smad3-mediated collagen I overproduction or ROS-induced NLRP3 inflammasome activation, these cells serve as a critical model to elucidate mechanisms of pathological extracellular matrix accumulation, myofibroblast hyperactivation, and impaired tissue remodeling.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).